Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Price

Showing results (171-180 of 260) with videos related to

Pageof 26
Sort By:
JACC. Cardiovascular Interventions|September 24, 2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX TrialJérémie Abtan, P Gabriel Steg, Gregg W Stone, et al.
Circulation. Cardiovascular Interventions|May 12, 2026
Use of Paclitaxel-Coated Balloons in the United States: Early Results From the AGENT Postapproval StudyChristina Lalani, Eric Secemsky, Yang Song, et al.
Thrombosis and Haemostasis|April 7, 2017
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX studyWilliam A Parker, Deepak L Bhatt, Jayne Prats, et al.
The Journal of Invasive Cardiology|May 30, 2006
A multicenter, randomized, dose-finding study of gamma intracoronary radiation therapy to inhibit recurrent restenosis after stentingMatthew J Price, Jeffrey W Moses, Martin B Leon, et al.
Structural Heart : the Journal of the Heart Team|December 1, 2025
Impact of Central vs. Noncentral Predominant Jet Location on Clinical Outcomes: Results From the EXPANDed StudiesJason H Rogers, Matthew J Price, Gagan D Singh, et al.
Circulation. Cardiovascular Interventions|August 13, 2017
Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention: Findings From CHAMPION PHOENIXMatthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.
JACC. Cardiovascular Interventions|October 25, 2023
1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 StudyRalph Stephan von Bardeleben, Paul Mahoney, M Andrew Morse, et al.
Circulation|January 15, 2016
Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) TrialMichelle L O'Donoghue, Deepak L Bhatt, Gregg W Stone, et al.
Circulation|August 3, 2016
Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)Matthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.
JAMA Cardiology|December 1, 2016
Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION TrialsMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Pageof 26

Showing results (171-180 of 260) with videos related to

Sort By:
Pageof 26
JACC. Cardiovascular Interventions|September 24, 2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX TrialJérémie Abtan, P Gabriel Steg, Gregg W Stone, et al.
Circulation. Cardiovascular Interventions|May 12, 2026
Use of Paclitaxel-Coated Balloons in the United States: Early Results From the AGENT Postapproval StudyChristina Lalani, Eric Secemsky, Yang Song, et al.
Thrombosis and Haemostasis|April 7, 2017
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX studyWilliam A Parker, Deepak L Bhatt, Jayne Prats, et al.
The Journal of Invasive Cardiology|May 30, 2006
A multicenter, randomized, dose-finding study of gamma intracoronary radiation therapy to inhibit recurrent restenosis after stentingMatthew J Price, Jeffrey W Moses, Martin B Leon, et al.
Structural Heart : the Journal of the Heart Team|December 1, 2025
Impact of Central vs. Noncentral Predominant Jet Location on Clinical Outcomes: Results From the EXPANDed StudiesJason H Rogers, Matthew J Price, Gagan D Singh, et al.
Circulation. Cardiovascular Interventions|August 13, 2017
Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention: Findings From CHAMPION PHOENIXMatthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.
JACC. Cardiovascular Interventions|October 25, 2023
1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 StudyRalph Stephan von Bardeleben, Paul Mahoney, M Andrew Morse, et al.
Circulation|January 15, 2016
Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) TrialMichelle L O'Donoghue, Deepak L Bhatt, Gregg W Stone, et al.
Circulation|August 3, 2016
Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)Matthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.
JAMA Cardiology|December 1, 2016
Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION TrialsMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Pageof 26